Previous Close | 32.20 |
Open | 32.65 |
Bid | 32.30 x 51100 |
Ask | 32.41 x 25600 |
Day's Range | 32.34 - 32.71 |
52 Week Range | 21.14 - 35.30 |
Volume | |
Avg. Volume | 2,348,144 |
Market Cap | 48.438B |
Beta (5Y Monthly) | 0.64 |
PE Ratio (TTM) | 32.67 |
EPS (TTM) | 0.99 |
Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | 0.29 (0.90%) |
Ex-Dividend Date | May 08, 2024 |
1y Target Est | 35.26 |
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall first-quarter performance.
Haemonetics (HAE) Q4 revenues were driven by an uptick in the Plasma and Hospital segments.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.